EPIRUS Biopharmaceuticals, Inc. Current Liabilities
EPIRUS Biopharmaceuticals, Inc. had Current Liabilities of $32.63 million as of 2016-03-31, per its 10-Q filed 2016-05-10.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesCurrent · last filed 2016-05-10
- 2016-03-31: Liabilities, Current $32.63M.
- 2015-12-31: Liabilities, Current $33.28M.
- 2015-09-30: Liabilities, Current $21.29M.
- 2015-06-30: Liabilities, Current $9.73M.
| Period end | Liabilities, Current | Liabilities, Current as first filed |
|---|---|---|
| 2016-03-31 | $32.63M 10-Q · filed 2016-05-10 | |
| 2015-12-31 | $33.28M 10-Q · filed 2016-05-10 | |
| 2015-09-30 | $21.29M 10-Q · filed 2015-11-16 | |
| 2015-06-30 | $9.73M 10-Q · filed 2015-08-12 | |
| 2015-03-31 | $6.16M 10-Q · filed 2015-05-13 | |
| 2014-12-31 | $7.38M 10-K · filed 2016-03-29 | |
| 2014-09-30 | $6.87M 10-Q · filed 2014-11-10 | |
| 2014-06-30 | $1.93M 10-Q · filed 2014-08-11 | |
| 2014-03-31 | $4.67M 10-Q · filed 2014-05-09 | |
| 2013-12-31 | $16.24M 10-K · filed 2015-03-31 | $14.89M 10-K · filed 2014-03-14 |
| 2013-09-30 | $16.25M 10-Q · filed 2013-11-04 | |
| 2013-06-30 | $17.50M 10-Q · filed 2013-08-05 | |
| 2013-03-31 | $16.33M 10-Q · filed 2013-05-03 | |
| 2012-12-31 | $19.63M 10-K · filed 2014-03-14 | |
| 2012-09-30 | $19.82M 10-Q · filed 2012-11-08 | |
| 2012-06-30 | $17.82M 10-Q · filed 2012-08-07 | |
| 2012-03-31 | $18.01M 10-Q · filed 2012-05-04 | |
| 2011-12-31 | $15.54M 10-K · filed 2013-03-07 | |
| 2011-09-30 | $13.21M 10-Q · filed 2011-11-04 | |
| 2011-06-30 | $10.71M 10-Q · filed 2011-08-04 | |
| 2010-12-31 | $9.04M 10-K · filed 2012-03-09 |